FutureMS cohort profile: a Scottish multicentre inception cohort study of relapsing-remitting multiple sclerosis
Patrick K. A. Kearns(University of Edinburgh), Siddharthan Chandran(Edinburgh Royal Infirmary), David Hunt(Mott MacDonald (United Kingdom)), Katarzyna Hafezi, Yingdi Chen, Christine Weaver(MRC Centre for Regenerative Medicine), Sarah J. Martin(NHS Greater Glasgow and Clyde), S. Thomson(Edinburgh Cancer Research), Adam Waldman(Royal Society of Edinburgh), Amy Stenson(MRC Centre for Regenerative Medicine), Elizabeth Freyer(Edinburgh Cancer Research), Rozanna Meijboom(MRC Centre for Regenerative Medicine), Adil Harroud(Montreal Neurological Institute and Hospital), Niall MacDougall(MRC Centre for Regenerative Medicine), Peter Connick(University of Cambridge), Elizabeth N. York(University of Edinburgh), J O’Riordan(Ninewells Hospital), Peter Foley(MRC Centre for Regenerative Medicine), Jessie Chang(Centers for Disease Control and Prevention), Margaret McLeod(Aberdeen Royal Infirmary), Lee Murphy(Western General Hospital), Francisco Javier Carod-Artal(Raigmore Hospital), Sergio E. Baranzini(University of California, San Francisco)
Cited by 15
Related Papers
Multiple sclerosis
|The Lancet|2018|1.8k
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
|Science|2019|1.4k
The Genome of the Kinetoplastid Parasite, <i>Leishmania major</i>
|Science|2005|1.4k
A Longitudinal Study of Abnormalities on MRI and Disability from Multiple Sclerosis
|New England Journal of Medicine|2002|863